Hospital
Carolinaeast Medical Center
Carolinaeast Medical Center was paid $22.86M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.
33Billing provider infoCAROLINAEAST MEDICAL CENTER
NEW BERN, NC 28560
NEW BERN, NC 28560
33aNPI1801852835assigned 04/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$22.86M
24GClaims525,028
24DCodes billed178
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#25 of 92
Median peer was paid$11.47M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SHERRON, TAMMY controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 66,980 | $1.88M | |
| 2019 | 79,750 | $2.24M | |
| 2020 | 61,718 | $1.75M | |
| 2021 | 68,475 | $2.84M | |
| 2022 | 72,075 | $4.00M | |
| 2023 | 86,540 | $4.91M | |
| 2024incomplete | 89,490 | $5.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 29,512 | 25,076 | $4.41M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 19,473 | 16,567 | $3.64M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 29,827 | 26,105 | $3.14M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10.0% | 4,147 | 3,661 | $2.28M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.7% | 5,453 | 5,029 | $854K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 3,832 | 3,239 | $597K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.5% | 1,513 | 1,335 | $564K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 5,861 | 5,478 | $428K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1.9% | 6,422 | 5,768 | $424K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 7,046 | 5,931 | $389K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 14,399 | 12,223 | $389K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.5% | 1,459 | 1,257 | $345K |
166 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 18,707 | $329K |
| 80053 | Comprehensive metabolic panel | 1.4% | 42,964 | $325K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 8,912 | $309K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 47,246 | $305K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 10,482 | $233K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,345 | $205K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,108 | $187K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 496 | $181K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,386 | $132K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,386 | $132K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,564 | $114K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,407 | $109K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 976 | $107K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,898 | $95K |
| 84484 | <1% | 13,757 | $94K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,276 | $86K |
| 36415 | Collection of venous blood by venipuncture | <1% | 44,476 | $80K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 257 | $77K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 195 | $76K |
| 73630 | <1% | 1,600 | $76K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 965 | $75K |
| 76801 | <1% | 811 | $73K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,972 | $70K |
| 73610 | <1% | 1,259 | $66K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,427 | $63K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,481 | $62K |
| 0240U | <1% | 428 | $60K | |
| 81001 | <1% | 18,731 | $59K | |
| 81025 | <1% | 7,925 | $58K | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 1,373 | $58K |
| 87400 | <1% | 4,135 | $58K | |
| 83690 | <1% | 8,299 | $55K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 139 | $51K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,153 | $49K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,135 | $47K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,031 | $44K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,378 | $44K |
| 83735 | <1% | 7,738 | $42K | |
| 73130 | <1% | 841 | $40K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,236 | $40K |
| 73030 | <1% | 907 | $40K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 166 | $39K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 525 | $38K |
| 80306 | <1% | 1,857 | $36K | |
| 87430 | <1% | 2,555 | $36K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,722 | $34K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 251 | $34K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,674 | $32K |
| 83880 | <1% | 1,126 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 636 | $29K |
| 97597 | <1% | 2,210 | $28K | |
| 84702 | <1% | 2,615 | $27K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 821 | $26K |
| J3490 | Unclassified drugs | <1% | 3,012 | $24K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 394 | $23K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 554 | $23K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 1,331 | $22K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,346 | $22K |
| 73564 | <1% | 520 | $21K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 194 | $21K |
| 73110 | <1% | 452 | $21K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 514 | $19K |
| 87210 | <1% | 4,032 | $19K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 292 | $18K |
| 84703 | <1% | 1,799 | $17K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 629 | $17K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 3,232 | $16K |
| 87081 | <1% | 2,297 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,302 | $15K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,830 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,767 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,618 | $13K |
| 82728 | <1% | 1,263 | $13K | |
| 73560 | <1% | 287 | $12K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,067 | $12K |
| 72100 | <1% | 277 | $10K | |
| 96376 | <1% | 331 | $10K | |
| 81003 | <1% | 3,899 | $9K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,854 | $9K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,488 | $9K |
| 93971 | <1% | 128 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,052 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 159 | $8K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,193 | $7K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 310 | $7K |
| 83550 | <1% | 944 | $7K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,248 | $6K |
| 90715 | <1% | 161 | $6K | |
| 87420 | <1% | 440 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 453 | $6K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 445 | $5K |
| A0425 | Ground mileage, per statute mile | <1% | 3,401 | $5K |
| 83540 | <1% | 956 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 460 | $5K |
| 86901 | <1% | 1,251 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 115 | $4K |
| 85379 | <1% | 301 | $3K | |
| 84439 | <1% | 345 | $3K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 58 | $3K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 524 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 190 | $3K |
| 83605 | <1% | 315 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 477 | $3K |
| J0461 | Injection, atropine sulfate, 0.01 mg | <1% | 472 | $3K |
| 87088 | <1% | 316 | $3K | |
| 82575 | <1% | 495 | $3K | |
| G0380 | Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 110 | $3K |
| 12001 | <1% | 80 | $2K | |
| 73502 | <1% | 87 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 313 | $2K |
| 73590 | <1% | 40 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 197 | $2K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 136 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,487 | $2K |
| 73140 | <1% | 43 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 375 | $2K |
| 11045 | <1% | 14 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 338 | $2K |
| 87040 | <1% | 162 | $1K | |
| 80051 | <1% | 185 | $1K | |
| 74018 | <1% | 31 | $1K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 315 | $1K |
| 97598 | <1% | 44 | $1K | |
| 73080 | <1% | 30 | $1K | |
| 76642 | <1% | 61 | $1K | |
| 96415 | <1% | 80 | $1K | |
| 10060 | <1% | 33 | $1K | |
| 84156 | <1% | 497 | $1K | |
| 80061 | Lipid panel | <1% | 72 | $1K |
| A4565 | Slings | <1% | 253 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 127 | $970.64 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 94 | $867.65 |
| 82378 | <1% | 58 | $775.70 | |
| 87186 | <1% | 89 | $729.06 | |
| 85610 | <1% | 242 | $693.62 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $666.09 |
| 73090 | <1% | 14 | $611.76 | |
| 96417 | <1% | 21 | $547.97 | |
| 85730 | <1% | 120 | $538.61 | |
| 29125 | <1% | 26 | $504.51 | |
| 72040 | <1% | 15 | $502.03 | |
| 80320 | <1% | 149 | $447.84 | |
| 82565 | <1% | 164 | $373.84 | |
| V2632 | Posterior chamber intraocular lens | <1% | 65 | $359.00 |
| 84520 | <1% | 150 | $336.71 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 26 | $315.14 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 53 | $311.24 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 31 | $269.82 |
| 29505 | <1% | 13 | $179.89 | |
| A0398 | Als routine disposable supplies | <1% | 190 | $160.06 |
| 86900 | <1% | 43 | $156.44 | |
| 87070 | <1% | 42 | $138.92 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 16 | $133.00 |
| 83883 | <1% | 12 | $129.28 | |
| 82310 | <1% | 12 | $82.44 | |
| 82784 | <1% | 13 | $81.20 | |
| 87205 | <1% | 42 | $68.95 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 63 | $59.85 |
| 85027 | <1% | 20 | $59.29 | |
| 84165 | <1% | 14 | $52.78 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 47 | $48.40 |
| 84460 | <1% | 134 | $42.71 | |
| 84100 | <1% | 25 | $41.37 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 62 | $35.20 |
| 96523 | <1% | 27 | $22.53 | |
| 82947 | <1% | 119 | $6.81 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHERRON, TAMMY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Carolinaeast Physicians | Pollocksville, NC | $8.57M |
| Carolinaeast Physicians | New Bern, NC | $4.02M |
| Carolinaeast Medical Center | New Bern, NC | $2.99M |
| Carolinaeast Physicians | Cape Carteret, NC | $310K |
| Carolinaeast Physicians | New Bern, NC | $294K |
| Carolinaeast Physicians | Havelock, NC | $134K |
| Carolinaeast Physicians | New Bern, NC | $81K |
| Carolinaeast Medical Center | New Bern, NC | $43K |
| Carolinaeast Medical Center | New Bern, NC | $41K |
| Carolinaeast Physicians | Jacksonville, NC | $23K |
| Carolina East Physicians | Vanceboro, NC | $23K |
| Carolinaeast Physicians | Jacksonville, NC | $17K |
| Carolinaeast Physicians | Morehead City, NC | $13K |
| Carolinaeast Physicians | New Bern, NC | $2K |
| Carolinaeast Physicians | New Bern, NC | $845.00 |
| Carolinaeast Physicians | New Bern, NC | $775.79 |
| Carolinaeast Physicians | New Bern, NC | $96.97 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.